In vitro and in vivo studies of local arterial gene delivery and transfection using lipopolyplexes-embedded stents.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Biomedical Materials Research. Part A

• Publication date

  2009-06-30

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1002/jbm.a.32488PMID 19569206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene Therapy for Restenosis

  2012cited by this paper
• Poly(beta-amino ester) and cationic phospholipid-based lipopolyplexes for gene delivery and transfection in human aortic endothelial and smooth muscle cells.

  2008cited by this paper
• Gene-eluting stents: adenovirus-mediated delivery of eNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis.

  2008cited by this paper
• Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents.

  2007cited by this paper
• Bio-mimetic composite matrix that promotes endothelial cell growth for modification of biomaterial surface.

  2007cited by this paper
• Controlled delivery of antisense oligodeoxynucleotide from cationically modified phosphorylcholine polymer films.

  2006cited by this paper
• Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design.

  2006cited by this paper
• Release of plasmid DNA from intravascular stents coated with ultrathin multilayered polyelectrolyte films.

  2006cited by this paper
• Biodegradable polymeric vectors for gene delivery to human endothelial cells.

  2006cited by this paper
• Layer-by-layer assembly of cationic lipid and plasmid DNA onto gold surface for stent-assisted gene transfer.

  2006cited by this paper
• Lipoplex gene transfer of inducible nitric oxide synthase inhibits the reactive intimal hyperplasia after expanded polytetrafluoroethylene bypass grafting.

  2006cited by this paper
• Narrative Review: Drug-Eluting Stents for the Management of Restenosis: A Critical Appraisal of the Evidence

  2006cited by this paper
• Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents.

  2006cited by this paper
• Gene-Eluting Stents: Comparison of Adenoviral and Adeno- Associated Viral Gene Delivery to the Blood Vessel Wall In Vivo

  2006cited by this paper
• Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes.

  2005cited by this paper
• Immobilization of gene vector on polyurethane surface using monoclonal antibody for site-specific gene therapy

  2005cited by this paper
• Site specific gene delivery in the cardiovascular system.

  2005cited by this paper
• Catheter-based prostacyclin synthase gene transfer prevents in-stent restenosis in rabbit atheromatous arteries.

  2004cited by this paper
• A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

  2004cited by this paper
• Delivery and expression of pDNA embedded in collagen matrices.

  2004cited by this paper
• The Innate Immune Response to Adenovirus Vectors

  2004cited by this paper
• Drug-eluting stents: caution and concerns for long-term outcome

  2004cited by this paper
• DNA delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid-controlled release coating: mechanisms of enhanced transfection

  2003cited by this paper
• Synthesis of poly(beta-amino ester)s optimized for highly effective gene delivery.

  2003cited by this paper
• Preclinical Evaluation of Inducible Nitric Oxide Synthase Lipoplex Gene Therapy for Inhibition of Stent-Induced Vascular Neointimal Lesion Formation

  2003cited by this paper
• Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience.

  2003cited by this paper
• Coronary restenosis: a review of mechanisms and management.

  2003cited by this paper
• Synthesis of poly (β-amino ester)s optimized for highly effective gene delivery

  2003cited by this paper
• Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo

  2002cited by this paper
• Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries.

  2002cited by this paper
• Gene Delivery to Pig Coronary Arteries from Stents Carrying Antibody-Tethered Adenovirus

  2002cited by this paper
• Intravascular local gene transfer mediated by protein-coated metallic stent.

  2001cited by this paper
• How a dentist's name became a synonym for a life-saving device: the story of Dr. Charles Stent.

  2001cited by this paper
• Restenosis after coronary placement of various stent types.

  2001cited by this paper
• Neutrophil, Not Macrophage, Infiltration Precedes Neointimal Thickening in Balloon-Injured Arteries

  2000cited by this paper
• An integrin-targeted non-viral vector for pulmonary gene therapy

  2000cited by this paper
• Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectors.

  2000cited by this paper
• Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans.

  2000cited by this paper
• Degradable Poly(β-amino esters): Synthesis, Characterization, and Self-Assembly with Plasmid DNA

  2000cited by this paper
• In vitro investigation of factors important for the delivery of an integrin-targeted nonviral DNA vector in organ transplantation.

  2000cited by this paper
• Gene delivery from a DNA controlled-release stent in porcine coronary arteries

  2000cited by this paper
• Clinical and angiographic follow‐up after balloon angioplasty with provisional stenting for coronary in‐stent restenosis

  1999cited by this paper
• Gelatin Behaviour in Dilute Aqueous Solution: Designing a Nanoparticulate Formulation

  1999cited by this paper
• Coronary-artery stents--gauging, gorging, and gouging.

  1998cited by this paper
• Gene therapy for restenosis: getting nearer the heart of the matter.

  1998cited by this paper
• Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/integrin interactions.

  1995cited by this paper
• Clinical Experience With the Palmaz‐Schatz Coronary Stent: Initial Results of a Multicenter Study

  1991cited by this paper
• Helix [UNK] Coil Transitions in Dilute Aqueous Collagen Solutions1

  1960cited by this paper
• The N-terminal amino acid residues of gelatin. 2. Thermal degradation.

  1954cited by this paper

• Biogenic Nanoparticles in Cardiovascular Disease: Current Insights and Future Prospects

  2026cites this paper
• Organic Nanoparticles in Progressing Cardiovascular Disease Treatment and Diagnosis

  2024cites this paper
• Surface Modifications of Medical Grade Stainless Steel

  2024cites this paper
• Development of Direct Grafting on Cyclic Olefin Copolymers to Improve Hydrophilicity by Using Bioactive Polymers

  2021cites this paper
• Mechanisms of nanoparticle formation and gene delivery of polyplex-based delivery systems

  2020cites this paper
• Poly(beta-amino ester)s as gene delivery vehicles: challenges and opportunities

  2020cites this paper
• Stent-based delivery of adeno-associated viral vectors with sustained vascular transduction and iNOS-mediated inhibition of in-stent restenosis

  2017cites this paper
• Advanced Stents for Cardiovascular Applications

  2016cites this paper
• Nanotechnology in Coronary Artery Stent Coating

  2016cites this paper
• Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems.

  2016cites this paper
• Advances in stent-mediated gene delivery

  2016cites this paper
• Gene Delivery from Stents for Prevention of In-Stent Restenosis

  2016cites this paper
• Nanomedicines for Restenosis Therapy

  2014cites this paper
• Endovascular stents and stent grafts in the treatment of cardiovascular disease.

  2014cites this paper
• Nanoparticle Drug- and Gene-eluting Stents for the Prevention and Treatment of Coronary Restenosis

  2014influential citation
• Liposomal surface coatings of metal stents for efficient non-viral gene delivery to the injured vasculature.

  2013cites this paper
• An Anti-CD34 Antibody-Functionalized Clinical-Grade POSS-PCU Nanocomposite Polymer for Cardiovascular Stent Coating Applications: A Preliminary Assessment of Endothelial Progenitor Cell Capture and Hemocompatibility

  2013influential citation
• ZEIN: NOVEL NATURAL POLYMER FOR NANOPARTICLE- AND FILM- MEDIATED GENE DELIVERY

  2013cites this paper
• Notch signaling and bone fracture healing

  2013cites this paper
• Nanotechnology-based gene-eluting stents.

  2013cites this paper
• Polyelectrolyte multilayers promote stent-mediated delivery of DNA to vascular tissue.

  2013cites this paper
• Gelatin coating to stabilize the transfection ability of nucleic acid polyplexes.

  2013cites this paper
• Substrate-mediated gene delivery from glycol-chitosan/hyaluronic acid polyelectrolyte multilayer films.

  2013cites this paper
• Endovascular Gene Delivery from a Stent Platform: Gene- Eluting Stents

  2013cites this paper
• Liposomes in diagnosis and treatment of cardiovascular disorders.

  2012cites this paper
• Liposomes for cardiovascular targeting.

  2012cites this paper
• A study of intracoronary gene transfer using stents coated with plasmid vectors

  2011cites this paper
• Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model

  2011cites this paper
• Effect of poly(ethylene glycol) diacrylate concentration on network properties and in vivo response of poly(β-amino ester) networks.

  2011cites this paper
• Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis

  2010cites this paper
• POLY(BETA-AMINO ESTERS) FOR CARDIOVASCULAR APPLICATIONS

  2010cites this paper